Brief: Angion Biomedica Corp On March 9, 2023 Co Novapark Entered Deal Which Terminated Agreement Of Lease, Dated As Of June 21, 2011 - SEC Filing
March 14 (Reuters) - Angion Biomedica Corp ANGN.O :
* ANGION BIOMEDICA CORP: ON MARCH 9, 2023 CO NOVAPARK
ENTERED DEAL
WHICH TERMINATED AGREEMENT OF LEASE, DATED AS OF JUNE 21, 2011 -
SEC FILING
* ANGION BIOMEDICA CORP: CO SHALL PAY TO NOVAPARK
TERMINATION FEE
OF $3.03 MILLION, CO AND NOVAPARK ENTERED INTO MEMBERSHIP
INTEREST REDEMPTION AGREEMENT
Source text: [ID:https://m5.gs/WFZIa0]
Further company coverage: ANGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elicio Therapeutics
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Elicio Therapeutics Q2 net loss narrows as R&D expenses fall
Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)